Document Detail


Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage.
MedLine Citation:
PMID:  21945644     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVE: To determine the efficacy of pazopanib eye drops in the streptozotocin induced diabetic retinopathy rat model. METHODS: A 0.5% w/v pazopanib suspension was prepared in phosphate buffered saline (PBS, pH 7.4) in the presence of 0.5% w/v sodium carboxymethyl cellulose. Brown Norway rats were divided into three groups (n=4) - (1) healthy, (2) diabetic, and (3) diabetic with treatment. The drug suspension was administered twice daily as eye drops to group 3 for 30days. Efficacy parameters including the number of adherent leukocytes in the retinal vasculature (leukostasis), blood-retinal FITC-dextran leakage, and vitreous-to-plasma protein ratio were measured. RESULTS: Pazopanib suspension in the form of eye drops significantly reduced leukostasis (32%), FITC-dextran leakage (39%), and the vitreous-to-plasma protein ratio (64%) in diabetic animals compared to untreated diabetic group. CONCLUSION: Pazopanib eye drops can alleviate retinal complications of diabetic retinopathy.
Authors:
Ashish Thakur; Robert I Scheinman; Vidhya R Rao; Uday B Kompella
Related Documents :
2908284 - Beta-blockers, lipoproteins and non-insulin dependent diabetes.
3236944 - Streptozotocin-induced diabetes in rat. ii. lipid and lipid peroxide changes of lipopro...
10569654 - Baseline characteristics of the study population in the diabetes atherosclerosis interv...
11792734 - Arterial smooth muscle cell proteoglycans synthesized in the presence of glucosamine de...
19885364 - New guideline supports the development and evaluation of continuous interstitial glucos...
18084674 - Diabetes and impaired glucose regulation in first-degree relatives of patients with typ...
Publication Detail:
Type:  -     Date:  2011-9-16
Journal Detail:
Title:  Microvascular research     Volume:  -     ISSN:  1095-9319     ISO Abbreviation:  -     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-9-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0165035     Medline TA:  Microvasc Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier Inc.
Affiliation:
Nanomedicine and Drug Delivery Laboratory, Department of Pharmaceutical Sciences, Aurora, CO 80045, USA; Department of Pharmaceutical Sciences, 985840 Nebraska Medical Center, Omaha, NE 68198-5840, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expression of Semaphorin 4F in neurons and brain oligodendrocytes and the regulation of oligodendroc...
Next Document:  Sun and sky: Does human vision assume a mixture of point and diffuse illumination when interpreting ...